| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $570K | +13.8% |
| R&D Expense | $19.2M | -37.8% |
| SG&A Expense | $11.1M | -16.0% |
| Operating Income | -$29.7M | +31.8% |
| Pre-tax Income | -$26.7M | +32.8% |
| Income Tax | $4K | +0.0% |
| Net Income | -$26.5M | +33.5% |
| EPS (Basic) | -$0.62 | +33.3% |
| EPS (Diluted) | -$0.62 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.0M | +20.6% |
| Short-term Investments | $5.0M | -88.0% |
| Current Assets | $30.0M | -53.4% |
| Total Assets | $30.2M | -54.9% |
| Current Liabilities | $2.4M | -83.8% |
| Long-term Debt | $0 | — |
| Total Liabilities | $2.4M | -83.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.1M | +2.5% |
| Investing Cash Flow | $37.4M | +59.9% |
| Financing Cash Flow | -$143K | -1.4% |
| +33.3% |
| Stockholders' Equity |
| $27.8M |
| -46.7% |